Simple Dipyrrin Analogues of Prodigiosin for Use as Colistin Adjuvants
- North Carolina State University, Raleigh, NC (United States); OSTI
- University of Notre Dame, IN (United States)
- North Carolina State University, Raleigh, NC (United States)
Multidrug resistant (MDR) bacteria are an increasing public health problem. One promising alternative to the development of new antibiotics is the use of antibiotic adjuvants, which would allow the continued use of FDA-approved antibiotics that have been rendered ineffective due to resistance. In this study, we report a series of dipyrrins and pyrrole derivatives designed as analogues of prodigiosin and obatoclax, several of which potentiate the activity of colistin against Klebsiella pneumoniae, with lead compounds also potentiating colistin against Acinetobacter baumannii and Pseudomonas aeruginosa.
- Research Organization:
- Washington Univ., St. Louis, MO (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC), Basic Energy Sciences (BES). Chemical Sciences, Geosciences & Biosciences Division (CSGB)
- Grant/Contract Number:
- FG02-05ER15661
- OSTI ID:
- 1976305
- Journal Information:
- ChemMedChem, Journal Name: ChemMedChem Journal Issue: 16 Vol. 17; ISSN 1860-7179
- Publisher:
- ChemPubSoc EuropeCopyright Statement
- Country of Publication:
- United States
- Language:
- English
Similar Records
Genome Sequences of Two Carbapenemase-Resistant Klebsiella pneumoniae ST258 Isolates
An Analysis of the Novel Fluorocycline TP-6076 Bound to Both the Ribosome and Multidrug Efflux Pump AdeJ from Acinetobacter baumannii
Journal Article
·
Wed Jun 18 20:00:00 EDT 2014
· Genome Announcements
·
OSTI ID:1629085
An Analysis of the Novel Fluorocycline TP-6076 Bound to Both the Ribosome and Multidrug Efflux Pump AdeJ from Acinetobacter baumannii
Journal Article
·
Mon Jan 31 19:00:00 EST 2022
· mBio (Online)
·
OSTI ID:1982984